A research technologist prepares a Tessa Therapeutics Pte. virus specific t-cells (VST) infusion for cancer patients as part of a clinical trial inside a good manufacturing practice (GMP) room at Singapore’s National Cancer Center (NCCS) in Singapore. (Photographer: Nicky Loh/Bloomberg)

Dassault to Buy Medidata in $5.7 Billion Health Data Push

(Bloomberg) -- Dassault Systemes SE, a maker of industrial design software, agreed to buy Medidata Solutions Inc. for $5.7 billion to gain a foothold in the fast-growing market for clinical trial t...

Bloomberg Quint

Add BloombergQuint App to Home screen.